We are live on ! Find out more
AC

Amia Capital Portfolio holdings

AUM $32.1M
1-Year Est. Return 0.56%
This Fund
S&P 500
This Quarter Est. Return
+22.35%
1 Year Est. Return
+0.56%
3 Year Est. Return
+30.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$122M
AUM Growth
+$9.23M
Cap. Flow
+$3.04M
Cap. Flow %
2.5%
Top 10 Hldgs %
87.08%
Holding
43
New
3
Increased
3
Reduced
32
Closed
5

Top Buys

Rank Stock Value
1
PBR icon
Petrobras
PBR
+$7.54M
2
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$7.23M
3
LSXMK
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
+$5.21M
4
FATE icon
Fate Therapeutics
FATE
+$204K
5
BDTX icon
Black Diamond Therapeutics
BDTX
+$180K

Top Sells

Rank Stock Value
1
LILA icon
Liberty Latin America Class A
LILA
+$4.88M
2
LSXMA
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
+$4.55M
3
GRFS
Grifois
GRFS
+$4.49M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$1.36M
5
MRNA icon
Moderna
MRNA
+$1.09M

Sector Composition

Rank Sector Weight
1 Healthcare 42.65%
2 Energy 7.14%
3 Materials 2.97%
4 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NKTR icon
26
Nektar Therapeutics
NKTR
$2.39B
$341K 0.28%
982
-541
-36% -$169K
CRSP icon
27
CRISPR Therapeutics
CRSP
$4.58B
$301K 0.25%
4,102
-2,263
-36% -$132K
SAGE
28
DELISTED
Sage Therapeutics
SAGE
$299K 0.25%
7,197
-3,962
-36% -$144K
SRRK icon
29
Scholar Rock
SRRK
$5.71B
$270K 0.22%
14,808
-8,154
-36% -$139K
FATE icon
30
Fate Therapeutics
FATE
$281M
$235K 0.19%
+6,838
New +$204K
ARVN icon
31
Arvinas
ARVN
$518M
$234K 0.19%
6,974
-3,841
-36% -$163K
BDTX icon
32
Black Diamond Therapeutics
BDTX
$101M
$206K 0.17%
+4,886
New +$180K
SGMO
33
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$194K 0.16%
21,644
-11,911
-35% -$111K
VYGR icon
34
Voyager Therapeutics
VYGR
$187M
$190K 0.16%
15,070
-8,290
-35% -$96.4K
AKCA
35
DELISTED
Akcea Therapeutics Inc
AKCA
$189K 0.16%
13,761
-7,576
-36% -$117K
WVE icon
36
Wave Life Sciences
WVE
$1.12B
$141K 0.12%
13,506
-7,437
-36% -$70K
KZR
37
DELISTED
Kezar Life Sciences
KZR
$68K 0.06%
1,311
-41
-3% -$2.07K
CDTX
38
DELISTED
Cidara Therapeutics
CDTX
$59K 0.05%
803
-350
-30% -$22.7K
LILA icon
39
Liberty Latin America Class A
LILA
$1.51B
– –
-725,295
Closed -$4.88M
XLK icon
40
PUT
State Street Technology Select Sector SPDR ETF
XLK
$115B
– –
-525,000
Closed -$263K
QTTB icon
41
Q32 Bio
QTTB
$450M
– –
-781
Closed -$218K
ICPT
42
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-6,067
Closed -$382K
MTEM
43
DELISTED
Molecular Templates, Inc.
MTEM
– –
-1,256
Closed -$250K
1
2

Similar funds

QI
Qualcomm Inc San Diego, California $32.1M AUM 5.35% 1-Year Est. Return
SAM
Sandbar Asset Management London, United Kingdom $30.5M AUM 46.07% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
AG
Appleton Group Appleton, Wisconsin $28.6M AUM 32.21% 1-Year Est. Return
NLG
New Legacy Group New York $36.6M AUM 36.77% 1-Year Est. Return
BEVI
Braemar Energy Ventures III New York $37.9M AUM 66.45% 1-Year Est. Return
BGDR
BC Gestao de Recursos Sao Paulo, Brazil $38.2M AUM
TAAM
Top Ace Asset Management Hong Kong $25.3M AUM 23.27% 1-Year Est. Return

Amia Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Amia Capital held 43 positions worth $122M, up 8.2% from $112M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Amia Capital's Q2 2020 filing shows 3 new, 3 increased, 32 reduced and 5 closed positions. Its largest new stake was Fate Therapeutics: 6,838 shares worth $235K. The largest sale was Liberty Latin America Class A, an estimated $4.88M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 54% a quarter earlier, followed by Energy and Materials.

  • Amia Capital's largest Q2 2020 buy was Fate Therapeutics: 6,838 shares worth $235K.
  • Amia Capital added most to Petrobras in Q2 2020, an estimated $7.54M increase.
  • Amia Capital's biggest Q2 2020 reduction was Liberty Media Corporation Series A Liberty SiriusXM Common Stock, cutting an estimated $4.55M.
  • Amia Capital fully exited Liberty Latin America Class A in Q2 2020, selling an estimated $4.88M.
  • Amia Capital's ten largest holdings make up 87% of its $122M portfolio in Q2 2020.
  • Amia Capital opened 3 new positions and closed 5 in Q2 2020.
  • Amia Capital's portfolio value rose 8.2% quarter-over-quarter to $122M.

Based on Amia Capital's 13F filing for Q2 2020, filed 14 Aug 2020.